| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9708 |
| Human Intestinal Absorption | HIA+ | 0.8382 |
| Caco-2 Permeability | Caco2+ | 0.7056 |
| P-glycoprotein Substrate | Non-substrate | 0.8831 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9869 |
| Non-inhibitor | 0.9855 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9176 |
| Distribution |
| Subcellular localization | Lysosome | 0.5587 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8305 |
| CYP450 2D6 Substrate | Non-substrate | 0.8225 |
| CYP450 3A4 Substrate | Non-substrate | 0.8082 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8827 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9240 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9566 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9488 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9815 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9015 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9462 |
| Non-inhibitor | 0.9716 |
| AMES Toxicity | Non AMES toxic | 0.9663 |
| Carcinogens | Carcinogens | 0.6381 |
| Fish Toxicity | Low FHMT | 0.6019 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.7833 |
| Honey Bee Toxicity | High HBT | 0.8000 |
| Biodegradation | Ready biodegradable | 0.9031 |
| Acute Oral Toxicity | III | 0.5847 |
| Carcinogenicity (Three-class) | Non-required | 0.4834 |